AI assistant
DEXCOM INC — Director's Dealing 2018
Oct 11, 2018
30198_dirs_2018-10-10_f4f7bd5d-7f86-4dfb-91cb-8044957c4611.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2018-10-08
Reporting Person: SAYER KEVIN R (Director, President, CEO & Chairman)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-10-08 | Common Stock | M | 11161 | $4.58 | Acquired | 331998 | Direct |
| 2018-10-08 | Common Stock | S | 6807 | $124.3178 | Disposed | 325191 | Direct |
| 2018-10-08 | Common Stock | S | 4354 | $125.4482 | Disposed | 320837 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-10-08 | Non-Qualified Stock Option (right to buy) | $4.58 | M | 11161 | Disposed | 2019-05-19 | Common Stock (11161) | Direct |
Footnotes
F1: On May 10, 2018, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan.
F2: Included in this number are 136,185 unvested restricted stock units, 80,545 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 40,640 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 15,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019.
F3: This transaction was executed in multiple trades at prices ranging from $124.00 to $124.97. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F4: This transaction was executed in multiple trades at prices ranging from $125.00 to $125.96. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.